Halpern D, Jensen O E, Grotberg J B
Department of Mathematics, University of Alabama, Tuscaloosa, Alabama 35487, USA.
J Appl Physiol (1985). 1998 Jul;85(1):333-52. doi: 10.1152/jappl.1998.85.1.333.
A computational study is presented for the transport of liquids and insoluble surfactant through the lung airways, delivered from a source at the distal end of the trachea. Four distinct transport regimes are considered: 1) the instilled bolus may create a liquid plug that occludes the large airways but is forced peripherally during mechanical ventilation; 2) the bolus creates a deposited film on the airway walls, either from the liquid plug transport or from direct coating, that drains under the influence of gravity through the first few airway generations; 3) in smaller airways, surfactant species form a surface layer that spreads due to surface-tension gradients, i.e., Marangoni flows; and 4) the surfactant finally reaches the alveolar compartment where it is cleared according to first-order kinetics. The time required for a quasi-steady-state transport process to evolve and for the subsequent delivery of the dose is predicted. Following fairly rapid transients, on the order of seconds, steady-state transport develops and is governed by the interaction of Marangoni flow and alveolar kinetics. Total delivery time is approximately 24 h for a typical first dose. Numerical solutions show that both transit and delivery times are strongly influenced by the strength of the preexisting surfactant and the geometric properties of the airway network. Delivery times for follow-up doses can increase significantly as the level of preexisting surfactant rises.
本文呈现了一项关于液体和不溶性表面活性剂通过肺气道传输的计算研究,这些物质从气管远端的一个源头输送进来。考虑了四种不同的传输机制:1)注入的团块可能形成一个液体栓塞,阻塞大气道,但在机械通气期间被推向周边;2)团块在气道壁上形成沉积膜,这要么源于液体栓塞的传输,要么源于直接涂布,该沉积膜在重力影响下通过最初几代气道向下引流;3)在较小的气道中,表面活性剂形成一个表面层,由于表面张力梯度(即马兰戈尼流)而扩散;4)表面活性剂最终到达肺泡腔,在那里它根据一级动力学被清除。预测了准稳态传输过程发展以及随后剂量输送所需的时间。在大约几秒的相当快速的瞬态之后,稳态传输发展起来,并由马兰戈尼流和肺泡动力学的相互作用控制。对于典型的首剂,总输送时间约为24小时。数值解表明,传输时间和输送时间都受到预先存在的表面活性剂的强度以及气道网络几何特性的强烈影响。随着预先存在的表面活性剂水平升高,后续剂量的输送时间可能会显著增加。